Archive for the ‘Member Press Releases’ Category

Pearl Pathways’ CEO completes Goldman Sachs 10,000 Small Businesses entrepreneurship program

July 6, 2016

PearlPathways

July 6, 2016

 

FOR IMMEDIATE RELEASE

 

Contact: Michele Taylor

Pearl Pathways

Business: (317) 899-9341 (ext. 112)

 

contact@pearlpathways.com 

www.pearlpathways.com

 

 

Indiana Life Science Executive completes Goldman Sachs 10,000 Small Businesses entrepreneurship program

 

Pearl Pathways’ Diana Caldwell welcomed into elite alumni group of the Babson College Cohort of Goldman Sachs’ 10,000 Small Business program

 

 

INDIANAPOLIS, INDIANA – July 6, 2016 — Pearl Pathways is pleased to announce that its President and CEO, Diana Caldwell recently completed an elite entrepreneurship training program in the Babson College Cohort of Goldman Sachs’ 10,000 Small Business program.  She is among 137 entrepreneurs who graduated in May 2016 representing 34 states, Washington D.C, and Puerto Rico.  Goldman Sachs 10,000 Small Businesses is a national program created to help entrepreneurs create jobs and economic opportunity by providing greater access to education, capital, and business support services. The graduates of the program this spring completed the blended online and face-to-face program that delivers intensive practical entrepreneurship training from Babson’s business experts and peers, alongside educational teams who teach the 10,000 Small Businesses program at community colleges across the country.

“We’re proud of our graduates of the Goldman Sachs 10,000 Small Businesses Initiative. These entrepreneurs put forth incredible effort to complete this program and we are confident their efforts will continue in growing their businesses. We are excited to watch their many successes,” said Kerry Healey, President of Babson College.

Pearl’s President and CEO, Diana Caldwell shares “The 10,000 Small Business program offered training for entrepreneurs that I was able to immediately implement in the business, and allowed me to network and learn from impressive CEOs across the country. I would recommend this program to fellow CEO’s who want to take their company to the next stage.”

Babson has been partnering with Goldman Sachs and others on the 10,000 Small Businesses program since 2010, and has helped train over 200 faculty and staff who deliver the program. The small businesses in this group represent a total of $240M in revenues and over 3,000 jobs from a broad range of industries.

Starting in March 2016, for 11 weeks, these small business owners connected with peers and worked together through practical business education delivered through a blend of online and in-person sessions.

“The program is designed to be highly participative, focusing on peer and experiential types of learning – just Babson’s style,” said Babson Professor Patricia Greene, National Academic Director of Goldman Sachs 10,000 Small Businesses and 10,000 Women. “Babson is proud to see these business owners applying what they have learned to take their next steps in growing their revenues, creating jobs, and supporting our economy.”

About Pearl Pathways

 

Pearl Pathways is a comprehensive life science product development services company. Our experienced team is obsessed with expediting life science product development regulatory pathways. We have three business units to serve you:

Pearl IRB is a full service commercial Independent Review Board that provides human research IRB reviews, IRB exemptions and waivers, and also offers support for research protocol/ICF medical writing, site assessments, and monitoring services.

Pearl ReGXP is a regulatory and quality compliance consulting practice that provides regulatory filing guidance, conducts global health authority negotiations, develops/improves quality systems, and delivers GMP/GLP/GCP auditing services.

Pearl IDEAS provides strategic product development assistance, third party vendor selection and management strategies, due diligence services, and sales and marketing services for drug, biologic and device companies.

To learn more, please visit us at www.pearlpathways.com, call us at (317) 899 – 9341, or email contact@pearlpathways.com. Pearl Pathways is located in Indianapolis, Indiana, and is AAHRPP accredited and a WBENC certified woman owned business. For media inquiries, contact contact@pearlpathways.com.

 

About Goldman Sachs 10,000 Small Businesses

Goldman Sachs 10,000 Small Businesses is based on the broadly held view of leading experts that greater access to this combination of education, capital and support services best addresses barriers to growth for small businesses. 10,000 Small Businesses is guided by an Advisory Council on which Babson President Kerry Healey serves and is co-chaired by Goldman Sachs chairman and CEO Lloyd C. Blankfein, Bloomberg L.P. founder, president and CEO, and 108th Mayor of the City of New York Michael R. Bloomberg, Berkshire Hathaway chairman and CEO Warren Buffett, and the Initiative for a Competitive Inner City’s Dr. Michael Porter.  The National Urban League and the U.S. Hispanic Chamber of Commerce are also represented on the Advisory Council, among other groups.

10,000 Small Businesses offers qualified business owners:

  • Guidance in creating a customized growth plan that includes opportunity identification and feasibility analysis, financial management, leadership, negotiations, and marketing.
  • One-on-one business counseling and a network of peer support from other small business owners, as well as leaders in the business world.

To apply for the 10,000 Small Businesses business and management education program, please visit www.10KSBapply.com.

About Babson College

Babson College is the educator, convener, and thought leader for Entrepreneurship of All Kinds®. The top-ranked college for entrepreneurship education, Babson is a dynamic living and learning laboratory where students, faculty, and staff work together to address the real-world problems of business and society. We prepare the entrepreneurial leaders our world needs most: those with strong functional knowledge and the skills and vision to navigate change, accommodate ambiguity, surmount complexity, and motivate teams in a common purpose to make a difference in the world, and have an impact on organizations of all sizes and types. As we have for nearly a half-century, Babson continues to advance Entrepreneurial Thought & Action® as the most positive force on the planet for generating sustainable economic and social value.

 

Thomas Medical Receives Indy Chamber GoGlobal Grant to Support Export Growth

June 3, 2016

IMG_1946_edit

[Indianapolis] — Thomas Medical has been awarded one of the Indy Chamber’s first GoGlobal grants, a new program in partnership with JPMorgan Chase to recognize and support the efforts of local employers to begin or expand exporting activity. To earn the competitive grant, Thomas Medical shared specific, practical plans to increase international sales over the next year.

“Thomas Medical is thrilled to be awarded a GoGlobal Grant from the Indy Chamber,” said Ben Ovenden, Sales Manager for Thomas Medical. “The incremental expenses associated with export growth can be prohibitive for smaller companies, so reaping the benefits of exporting, such as job growth, can seem daunting. Support like the Indy Chamber’s Global Indy Initiative goes a long way to keeping local companies on the global market.”

 
The grant announcement was made at the Indy Chamber’s 2016 World Trade Day, an annual event highlighting the impact of global trade and investment in the Indianapolis region. Exports and foreign investment support more than 100,000 local jobs, with Indianapolis companies selling nearly $15 billion in goods and services outside the U.S. last year.

 
“Indy ranks 23rd out of the 100 largest metro areas in total exports, but the successful exporters in our community are far outnumbered by companies who aren’t taking advantage of global opportunities,” said Michael Huber, president and CEO of the Indy Chamber. “With the support of JPMorgan Chase, the GoGlobal grant program will help businesses explore new markets and find new customers around the world – and inspire others to follow suit.”

 

Thomas Medical will use the grant funds to participate in the annual meeting of the European Society of Human Reproduction and Embryology (ESHRE), July 3-6 in Helsinki, Finland.

 
The GoGlobal Grant awards are part of the Indy Chamber’s Global Indy initiative, which exists to encourage the Indy metro’s companies to engage in global opportunities through export support and facilitating foreign direct investment activity.

 
For more information about the GoGlobal Grant awards, visit IndyChamber.com/GoGlobalGrant.

IHIF Welcomes CRI Medical Devices as New Member!

March 14, 2016

CRI - Full logo

CRI is a global full service medical device manufacturer specializing in class I, II & III single-use medical devices, concept development and product life cycle management. With three decades of experience, CRI® has a dedicated staff focused on customer needs to ensure a high level of satisfaction.

Learn more at http://www.cri-devices.com/en

Anagin Lands Health Grant

March 11, 2016

Posted: Mar 10, 2016 6:18 PM

Updated: Mar 11, 2016 9:15 AM

Source:http://www.insideindianabusiness.com/story/31441356/iu-startup-lands-health-grant 

Eric Messner (photo courtesy of IU)
Eric Messner (photo courtesy of IU)
INDIANAPOLIS –An Indianapolis-based startup that uses technology from Indiana University has received a large grant. The National Institute of Neurological Disorders and Stroke awarded Anagin LLC a $267,000 grant to test benefits of a compound to treat damage caused by traumatic brain injury.

IU says Xiao-Ming Xu, scientific director of the Spinal Cord and Brain Injury Research Group in the Stark Neurosciences Research Institute, is a sub-awardee for the grant. Anagin CEO Eric Messner says Xu will conduct the most important portions of the research at the IU School of Medicine.

“There is a critical need to understand the molecular mechanisms underlying functional deficits after traumatic brain injury,” said Messner. “There is also a need to translate this knowledge into the development of new treatments.”

Xu says the research will investigate an optimal dose of the compound and whether it retains its efficacy “when administered in a delayed reaction.”

Anagin has previously been awarded similar grants to test its compounds to treat post-traumatic stress disorder. It also won the BioCrossroads New Venture Competition in 2014.

CRI Medical Devices Facility Move is Now Complete

March 2, 2016

For Immediate Release
CRI Medical Devices Facility Move is Now Complete
Indianapolis, Indiana

February 25, 2016

 
CRI is pleased to announce the move to its new facility has been completed. The new facility is located at 6102 Victory Way Indianapolis, IN 46278 in Park 100. It can be seen from Interstate 465 just before 71st Street.

CRI
Over the past 6 months, CRI has been preparing for a facility move which would significantly increase production and warehouse capacity while accommodating the growing global support teams such as finance, quality, engineering and business development. “We were fortunate to find such a nice space so close to our former facility. We really wanted to limit the impact that relocation could have on our customers and our employees; I don’t think we could have found a better location for our team. Our new location, with enhanced operational capacity, allows us to scale and meet the needs of an ever demanding medical device marketplace, while providing exceptional product quality along the way,” said Mike Andrus, CRI’s EVP of Commercial Operations.

 

About CRI
CRI is a global full service medical device manufacturer specializing in class I, II & III single-use medical devices, concept development and product life cycle management. With three decades of experience, CRI has a dedicated staff focused on customer needs to ensure a high level of satisfaction.

 
For more information please visit www.cri-devices.com or email info@cri-devices.com.

Marketing Team CRI®

marketing@cri-devices.com

IHIF Welcomes Alzheimer’s Association of Greater Indiana as New Member!

February 8, 2016

Alzheimers Assoc Logo

The Alzheimer’s Association Greater Indiana Chapter provides education, care and support o 73 counties across the sate of Indiana. We raise funds and awareness about the disease for the more than 110,000 Hooisers living with Alzheimer’s disease and their 332,000 caregivers. Our local advocates work with Indiana legislators to make Alzheimer’s disease a priority in policy making. Additionally, we help nearly 300,000 people annually by offering support, information and referrals though (800.272.3900) staffed by specialists and master’s level clinicians.

Learn more at www.alz.org/indiana/

BIO Releases First-Ever Industry Principles on Value of Biopharmaceuticals

February 5, 2016

BIO Logo Horizontal RGB

News Release

1201 Maryland Avenue, SW l Ste. 900

Washington, D.C. l 20024 l 202-962-9200

Web: www.bio.org

Blog: www.biotech-now.org

Twitter: @IAmBiotech

For Immediate Release

Contact:Daniel Seaton
202-470-5207

BIO Releases First-Ever Industry Principles on Value of Biopharmaceuticals

Innovative biopharmaceutical industry focused on value, advocating for needed reforms

Washington, D.C. (February 3, 2016) – The Biotechnology Innovation Organization (BIO) today released new Principles on the Value of Biopharmaceuticals. These voluntary Principles represent the first-ever systemic, industry-endorsed set of commitments by research-based biopharmaceutical companies to support comprehensive and sustainable solutions to improve patient access to and affordability of innovative medicines that are transforming how we treat and cure patients with once-devastating diseases.

The following statement may be attributed to BIO President and CEO Jim Greenwood:

“America’s innovative biopharmaceutical companies exist to advance the health and well-being of patients by tackling head-on the unrelenting scientific challenges inherent in the discovery, development and delivery of new, high-value cures and treatments. These Principles represent a commitment by our industry to do our part to improve the ability of patients to access those medicines on a sustainable and affordable basis, while also continuing to take the big risks and make the enormous investments required to fulfill the promise of the next generation of cures.”

Among other principles, BIO members are committed to open dialogue with patients, healthcare providers, and payers on the value of their biopharmaceutical innovations and to take these stakeholders’ views into account in the development and delivery of such cures and treatments.  In addition, BIO and its members will work with such stakeholders, as well as policymakers, to explore a broad range of novel delivery approaches to maximize the value of these innovations for patients and the overall healthcare system, including by seeking to remove legal barriers that currently limit the ability to engage in value-based contracting and communications.

“As evidenced by these Principles, the research-based biopharmaceutical industry welcomes the vigorous public debate about the cost and value of our medical innovations,” Greenwood said.  “BIO members already are doing their part to find sustainable patient-centered solutions, and as an industry we are committed to doing even more.  To effectively accomplish these goals, it is essential that other stakeholders in the healthcare system do their part, as well. To that end, we call upon payers, healthcare providers and policymakers to join with us in designing and implementing comprehensive solutions that will ensure patients continue to benefit from the tremendous medical advances biotechnology has made possible.”

The full Principles on the Value of Biopharmaceuticals are available here. To learn more about the value of innovation, please visit here.

About BIO

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

IHIF Welcomes Johnson Co. EDC as new Member!!

January 26, 2016

jcdc logo

A non-profit public/private partnership that provides economic development services to municipalities and companies throughout Johnson County.

 

Learn more at www.jcdc.org

Pearl Pathways participates in program to drive second-stage growth

January 11, 2016

January 7, 2016

FOR IMMEDIATE RELEASE
Contact: Diana Caldwell
Pearl Pathways
Business: (317) 899-9341
Cell: (317) 490-0511
contact@pearlpathways.com
www.pearlpathways.com

Life sciences consulting company selected for prestigious Purdue Economic Gardening Program

INDIANAPOLIS, INDIANA – January 7, 2016 — Pearl Pathways, a comprehensive life science product development services company, is excited to announce its’ participation in the Purdue Economic Gardening Program.

The Economic Gardening program is managed by the Purdue Center for Regional Development with funding provided from a gift from the Lilly Endowment Inc.

Using an entrepreneurial approach to promote business growth, the Purdue Economic Gardening Program provides tailored assistance to second-stage companies. The program states that economic gardening “is about leveraging information using sophisticated business intelligence tools and databases that growth companies either aren’t aware of or cannot afford.”1 Four focus areas of the program include providing information that helps companies define core business strategies, delivering market intelligence, assisting in efforts to identify qualified leads, and contributing to the company’s leadership development. Purdue collaborates with the businesses to work through barriers and develop new methods.

Purdue and Pearl Pathways will focus on market intelligence analysis, geographical mapping, search engine optimization, and analyzing key industry trends. Diana Caldwell, CEO & President, states, “We are thrilled to have been selected for the program. This will allow us access to data and experts that can provide great insights into our business and the marketplace. The highly-skilled Economic Gardening team has been a pleasure to work with, and we are confident that the information they can provide will impact our business planning priorities and day to day efforts with our clients.”PearlPathways

BioStorage Technologies:Innovative Sample Management Partnership is Advancing Precision Medicine to Find Cure for IBD

November 19, 2015

INDIANAPOLIS – As the global leader in comprehensive sample management solutions, BioStorage Technologies has entered into a strategic partnership with the Crohn’s & Colitis Foundation of America (CCFA) to provide innovative sample management and transformative technology servicers across the entire sample lifecycle including logistics, kitting, bioprocessing, storage and distribution of samples for its new IBD Plexus initiative.

 

Earlier this year, CCFA was awarded a grant from The Leona M. and Harry B. Helmsley Charitable Trust to establish an integrated knowledge platform designed to centralize and aggregate patient information – with linked biosamples – across multiple research efforts. The new initiative, called IBD Plexus, is designed to speed progress toward precision medicine through novel research, leading to better diagnostics, treatments and, ultimately cures for Crohn’s disease and ulcerative colitis, also known as inflammatory bowel diseases (IBD).

 

IBD Plexus will enable academic and industry researchers, clinicians, and other healthcare providers to study IBD in patients of all ages. The initiative will nurture collaboration among stakeholders and is powered by a common goal of supporting better care, improving treatments, and finding a cure.

 

The IBD Plexus research project includes a biobank; registries to capture clinical, patient-reported, and biosample data (genetic, genomic, microbiomic, etc.); and a large data management platform to house, organize, aggregate, and disseminate data to support research decisions. Within three years, databases will be combined or built with clinical information on more than 40,000 Crohn’s and colitis patients, along with genomic and microbial profiles from 7,000 patients who will be followed over time.

 

IBD Plexus’s sample management and technology services platform will be provided by BioStorage Technologies. In addition, BioStorage will be relocating a sample collection and performing DNA extraction through its BioProcessing Solutions Alliance with RUCDR Infinite Biologics.

 

“We are honored to collaborate with CCFA’s IBD Plexus to support their delivery of personalized medicine to patients with IBD and the advancement of the search for the cure,” said Greg Swanberg, CEO, BioStorage Technologies.

 

“IBD Plexus will provide the infrastructure and capacities to dramatically shift the paradigm and accelerate IBD research. We are pleased to be working with BioStorage Technologies as a partner in this important initiative,” said Dr. Caren Heller, Chief Scientific Officer for CCFA.

 

“This project embodies the Helmsley Charitable Trust’s commitment to establishing close and productive partnerships with the organizations that offer the greatest potential to impact the areas that we support,” said Helmsley Charitable Trust trustee Sandor Frankel. “We are thrilled at the prospects of what this important new research platform can achieve in advancing therapies, care and the path to a cure for those with IBD with the support of best-in-class partners.”

 

About Biostorage Technologies 

BioStorage BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering flexible onsite, offsite and hybrid models for the smartsourcing of research assets, BioStorage Technologies provides a complete life-cycle of sample management solutions. With an expert team of global sample consultants, industry-leading temperature-controlled storage facilities, innovative bioprocessing solutions and state-of-the-art technology solutions to support sample inventory and data virtualization, the company supports its customers in maximizing opportunities, minimizing risk and reducing costs. BioStorage Technologies, Inc. is a privately held, global corporation. For more information, visit www.biostorage.com or call +1 866 697 2675 for North America, +49 6155 898 1011 for Europe or +65 31576199 for Singapore or +86 10 8587 2390 for China.

 

About CCFA

The Crohn’s & Colitis Foundation of America (CCFA) is the largest non-profit voluntary health agency dedicated to finding cures for inflammatory bowel diseases (IBD). CCFA’s mission is to cure Crohn’s disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit www.ccfa.org or call 888-694-8872.

 

About CCFA

The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional nonprofits and other mission-aligned organizations in the U.S. and around the world in health, selected place-based initiatives, and education and human services. Through its IBD and Crohn’s Disease Program, the Trust has allocated nearly $160 million to institutions in the United States, Canada, Europe, and Israel. Across the program, nearly 100 Helmsley-funded investigators are working to understand both how human genetics and the gut microbiome can cause and exacerbate IBD and bring those insights into the development of new treatments and a cure. For more information, please visit www.helmsleytrust.org.

 


Follow

Get every new post delivered to your Inbox.

Join 259 other followers